Sort
48,018 grants matching “immunotherapy”
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$394,959Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$394,916Song Li · University Of California Los Angeles · R01 · FY2022 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$394,916Song Li · University Of California Los Angeles · R01 · FY2023 · CA
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells
$394,894Ning Jenny Jiang · University Of Pennsylvania · R33 · FY2021 · CA
Effects of Complement on the Tumor Microenvironment in Lung Cancer
$394,879Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2022 · CA
Effects of Complement on the Tumor Microenvironment in Lung Cancer
$394,879Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2023 · CA
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
$394,856Haian Fu · Emory University · P01 · FY2022 · CA
Regulation of Tumor Microenvironment in Cancer
$394,854Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2014 · CA
MYC activation in tumor progression of neuroblastoma
$394,841Min Hee Kang · Texas Tech University Health Scis Center · R01 · FY2020 · CA
Neural Stem Cell Carriers for Glioblastoma Immunotherapy
$394,803Irina V Balyasnikova · Northwestern University At Chicago · R33 · FY2019 · NS
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$394,792Craig Lee Slingluff · University Of Virginia · R01 · FY2017 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$394,792Craig Lee Slingluff · University Of Virginia · R01 · FY2016 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$394,792Craig Lee Slingluff · University Of Virginia · R01 · FY2015 · CA
S100A4 mediated immune suppression in GBM
$394,788Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2025 · NS
Enhancing antitumor efficacy by intratumoral delivering LAIR1 inhibitory signaling
$394,687Jianping Huang · University Of Florida · R21 · FY2025 · CA
TNF Mediated Immune Defense Against Listeria Infection
$394,679Eric G Pamer · Sloan-Kettering Inst Can Research · R01 · FY2007 · AI
Clinical Scholars Biomedical Research Training Program
$394,664Ping Chi · Sloan-Kettering Inst Can Research · T32 · FY2018 · CA
Development of Novel Antibody Conjugates for Cancer Immunotherapy
$394,661Weiping Tang · University Of Wisconsin-Madison · R01 · FY2024 · CA
IMMUNOTHERAPY PROTECTION &VACCINES FOR HEPATITIS C
$394,651Rockefeller University · R01 · FY2002 · CA
Role of epithelial barrier function in food-induced anaphylaxis
$394,641Catherine Mary Ptaschinski · University Of Michigan At Ann Arbor · R01 · FY2024 · AI
Role of epithelial barrier function in food-induced anaphylaxis
$394,641Catherine Mary Ptaschinski · University Of Michigan At Ann Arbor · R01 · FY2025 · AI
Role of epithelial barrier function in food-induced anaphylaxis
$394,641Catherine Mary Ptaschinski · University Of Michigan At Ann Arbor · R01 · FY2023 · AI
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis
$394,591Lanlan Shen · Baylor College Of Medicine · R01 · FY2025 · CA
Immunotherapy for Renal Cell Carcinoma
$394,585Marc S Ernstoff · Dartmouth College · R01 · FY2008 · CA
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology
$394,579Gerard C Blobe · Duke University · R01 · FY2023 · CA